Yuanhe Origin

Yuanhe Origin (元禾原点) is an early-stage venture fund that has co-invested alongside FreeS Fund (峰瑞资本) in multiple deals spanning biotech and hardware, per FreeS Fund's own reporting. In 2018, it led the angel round in Singleron Biotechnologies, a single-cell sequencing startup founded that January by a Yale professor, with FreeS Fund following on . It also participated in Singleron's subsequent pre-A round in 2019 alongside Sherpa Capital and Huachuang Capital . More recently, Yuanhe Origin has surfaced as a lead investor in FreeS Fund portfolio companies across different sectors: it co-led SPEEDIANCE's RMB 50 million funding round in 2023 and led Chuguang 3D's angel-plus round in 2025, in both cases with FreeS Fund participating or re-upping . A Yuanhe Origin partner, Zhu Bin, has appeared at industry events discussing frontier-tech investment trends . The fund appears to operate as part of the broader Yuanhe ecosystem, though the retrieved materials do not specify its exact legal relationship to Yuanhe Capital or Yuanhe Puhua .